Fingerprint
Dive into the research topics of 'A phase I, open-label, dose-escalation, multicenter study of the JAK2 inhibitor NS-018 in patients with myelofibrosis'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
A phase I, open-label, dose-escalation, multicenter study of the JAK2 inhibitor NS-018 in patients with myelofibrosis
S. Verstovsek, M. Talpaz, E. Ritchie, M. Wadleigh, O. Odenike, C. Jamieson, B. Stein, T. Uno, R. A. Mesa
Research output: Contribution to journal › Article › peer-review
22
Scopus
citations